Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Infection Prevention, IU Health, Indianapolis, Indiana, USA.
Gastrointest Endosc. 2021 Apr;93(4):927-931. doi: 10.1016/j.gie.2020.07.057. Epub 2020 Jul 31.
The potential for transmission of pathogenic organisms is a problem inherent to the current reusable duodenoscope design. Recent outbreaks of multidrug-resistant pathogenic organisms transmitted via duodenoscopes has brought to light the urgency of this problem. Microbiologic culturing of duodenoscopes and reprocessing with repeat high-level disinfection (HLD) or liquid chemical sterilization (LCS) have been offered as supplemental measures to enhance duodenoscope reprocessing by the U.S. Food and Drug Administration. This study aims to compare the efficacy of reprocessing duodenoscopes with double HLD (DHLD) versus LCS.
We prospectively evaluated 2 different modalities of duodenoscope reprocessing from October 23, 2017 to September 24, 2018. Eligible duodenoscopes were randomly segregated to be reprocessed by either DHLD or LCS. Duodenoscopes were randomly cultured after reprocessing for surveillance based on an internal protocol.
During the study period, there were 878 post-reprocessing surveillance cultures (453 in the DHLD group and 425 in the LCS group). Of all cultures, 17 were positive for any organism (1.9%). There was no significant difference of positive cultures when comparing the duodenoscopes undergoing DHLD (8 positive cultures, 1.8%) with duodenoscopes undergoing LCS (9 positive cultures, 2.1%; P = .8). Both groups had 2 cultures that grew high-concern organisms (.5% vs .5%, P=1.0). No multidrug-resistant organisms, including carbapenem-resistant enterobacteriaceae, were detected.
DHLD and LCS both resulted in a low rate of positive cultures, for all organisms and for high-concern organisms. However, neither process completely eliminated positive cultures from duodenoscopes reprocessed with 2 different supplemental reprocessing strategies.
当前可重复使用的十二指肠镜设计固有地存在传播病原体的潜在风险。最近,通过十二指肠镜传播的多药耐药病原体爆发,凸显了这一问题的紧迫性。美国食品和药物管理局提出对十二指肠镜进行微生物培养,并采用重复高水平消毒(HLD)或液体化学灭菌(LCS)进行重复处理,作为增强十二指肠镜处理的补充措施。本研究旨在比较重复 HLD(DHLD)与 LCS 处理十二指肠镜的效果。
我们前瞻性地评估了 2017 年 10 月 23 日至 2018 年 9 月 24 日期间 2 种不同的十二指肠镜处理方式。将符合条件的十二指肠镜随机分为 DHLD 或 LCS 处理。根据内部方案,对处理后的十二指肠镜进行随机培养,以进行基于监测的培养。
在研究期间,共进行了 878 次处理后监测培养(DHLD 组 453 次,LCS 组 425 次)。所有培养物中,有 17 次培养物检测到任何病原体(1.9%)呈阳性。比较 DHLD 处理的十二指肠镜(8 次阳性培养,1.8%)与 LCS 处理的十二指肠镜(9 次阳性培养,2.1%;P=0.8),阳性培养物无显著差异。两组各有 2 次培养物检出高关注病原体(0.5%比 0.5%,P=1.0)。未检出耐多药病原体,包括耐碳青霉烯类肠杆菌科细菌。
DHLD 和 LCS 两种方法处理的十二指肠镜的培养物阳性率均较低,所有病原体和高关注病原体的阳性率均较低。然而,两种处理方法均不能完全消除用两种不同补充处理策略处理后的十二指肠镜的阳性培养物。